The KINERET logo and generic name (anakinra)

KINERET Support Program

Meet Quinn and her mother, Colleen.


Quinn had signs of NOMID from birth.

"No one at the hospital—not even the chief neonatologist—had ever seen anything like Quinn’s constellation of symptoms."—Colleen, Quinn's mother

Quinn is smiling while looking out the window during ballet rehearsal.

Each NOMID patient’s path to diagnosis is unique—and like most, Quinn's was complex.

"During the first 6 months of Quinn’s life, we were referred to specialist after specialist—12, to be exact. She underwent countless tests and tried various forms of treatment with no relief."—Colleen, Quinn's mother

When your child is seriously ill, obtaining a diagnosis can be a relief.

"At this point, however, there was nothing we wouldn’t have tried if it meant there was even a possibility it would help our daughter."—Colleen, Quinn's mother

Quinn staring at the camera smiling, while holding the handlebars of her bicycle

In Quinn’s case, KINERET reduced the signs and symptoms of NOMID.

"It was a turning point in a year of suffering: Quinn’s NOMID diagnosis had led us to the treatment that might be right for her."—Colleen, Quinn's mother

Injecting KINERET is now part of Quinn’s daily routine.

"I’m not gonna lie. For a long time, she put up a fight about it almost every time, but, hey, she’s a kid! That's kind of her job, right? She doesn’t fight it so much anymore; she understands that she needs her injections. If for some reason our routine is off or we’re running late, she’s the first one to remind me: 'Mommy, you forgot my KINERET.'"—Colleen, Quinn's mother

INDICATIONS

What is KINERET (anakinra)?

KINERET is a prescription medicine called an interleukin-1 receptor antagonist (IL-1Ra) used to:

  • Reduce signs and symptoms and slow the damage of moderate to severe active rheumatoid arthritis (RA) inadults when one or more other drugs for RA have not worked
  • Treat people with a form of Cryopyrin-Associated Periodic Syndromes (CAPS) called Neonatal-OnsetMultisystem Inflammatory Disease (NOMID)
  • Treat people with Deficiency of Interleukin-1 Receptor Antagonist (DIRA)

Kineret is not for children with Juvenile Rheumatoid Arthritis.

IMPORTANT SAFETY INFORMATION

Who should not receive KINERET?

You should not receive KINERET if you are allergic to proteins made from bacteria called E. coli or any of the ingredients in KINERET.

What should I tell my healthcare provider before taking KINERET?

You should tell your doctor if you:

  • Have an infection, a history of infections that keep coming back, or other problems that can increase your risk of infections.
  • Are scheduled to receive any vaccines since people using KINERET should not receive live vaccines.
  • Have kidney problems.
  • Are pregnant, planning to become pregnant, or breastfeeding. It is not known if KINERET will harm your unborn baby or passes into your breastmilk. You and your healthcare provider should decide if you will use KINERET or breastfeed.

What are the serious side effects of KINERET?

KINERET can lead to serious infections, including tuberculosis (TB). Because KINERET is a medicine that affects your immune system and may lower your risk to fight infection, your doctor may test for TB and treat new or unknown TB, before you start taking KINERET.

You Should Know: Signs and symptoms of a serious infection could include fever, chills, or excessive sweating, open sores on your body, nausea, lightheadedness, or vomiting, dizziness or lightheadedness.

You should tell your healthcare provider or get medical help if new symptoms of an infection appear. They can be life-threatening or cause death.

You should stop using KINERET and call your healthcare provider or get emergency help right away if you have any of these symptoms of an allergic reaction: swelling of your face, lips, mouth, or tongue; trouble breathing; wheezing; severe itching; skin rash, redness, or swelling outside of the injection site area; dizziness or fainting; fast heartbeat or pounding in your chest (tachycardia); or sweating. People with DIRA may have an increased risk of allergic reactions, especially in the first several weeks.

It is not known if treatment with medicines that cause immunosuppression, like KINERET, affect your risk of getting cancer.

KINERET may cause you to have a lower number of certain white cells (neutrophils). Neutrophils are important in fighting infections. You should have blood tests before starting treatment with KINERET, then monthly for 3 months. After the first 3 months you should have your blood tested every 3 months for up to 1 year.

Before taking KINERET, you should tell your healthcare provider about all your medical conditions and medicines including prescription and over-the-counter medicines, vitamins, supplements, and herbal remedies.

What are other possible side effects of KINERET?

The most common side effects of KINERET include injection site skin reactions, worsening RA (if you already have RA), headache, nausea and vomiting, diarrhea, joint pain, fever, general feeling of discomfort, sore throat or runny nose, sinus infection, and pain in your stomach area.

You Should Know: These are not all the possible side effects for KINERET. For more information, ask your healthcare provider or review the Prescribing Information for KINERET at https://www.kineretrx.com/pdf/Full-Prescribing-Information-English.pdf.

If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.

You Should Know: These are not all the possible side effects for KINERET. For more information, ask your healthcare provider or review the Prescribing Information for KINERET at https://www.kineretrx.com/pdf/Full-Prescribing-Information-English.pdf.

If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.